Genome British Columbia: Supergenes play a larger role in evolution than previously thought
July 08, 2020 11:30 ET
|
Genome British Columbia; University of British Columbia (UBC)
VANCOUVER, British Columbia, July 08, 2020 (GLOBE NEWSWIRE) -- Massive blocks of genes—inherited together ‘plug and play’ style—may play a larger role in evolutionary adaption than previously...
Exactus Announces its Hemp Seed Buyback Program to Assist Farmers Impacted by the COVID-19 Pandemic
May 28, 2020 08:00 ET
|
Exactus Inc.
DELRAY BEACH, Fla., May 28, 2020 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB: EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD) and feminized hemp genetics, announced today the...
Hygea and Admera Health, a CLIA Certified/CAP Accredited Laboratory, Announce Formal Partnership
May 26, 2020 09:13 ET
|
Admera Health, LLC
SAN FRANCISCO and SOUTH PLAINFIELD, N.J., May 26, 2020 (GLOBE NEWSWIRE) -- Hygea Precision Medicine (Hygea), a company focused on developing a precision medicine software system for healthcare...
CORRECTION -- Exactus, Inc. Launches a Genetics Division to Supply Farmers with USDA Compliant Feminized CBD and CBG Hemp Seeds
April 28, 2020 10:54 ET
|
Exactus Inc.
DELRAY BEACH, Fla., April 28, 2020 (GLOBE NEWSWIRE) -- In a release issued under a similar headline today, April 28th by Exactus, Inc. (OTCQB:EXDI), please note that in the headline and opening...
Exactus, Inc. Launches a Genetics Division to Supply Farmers with FDA Compliant Feminized CBD and CBG Hemp Seeds
April 28, 2020 08:00 ET
|
Exactus Inc.
DELRAY BEACH, Fla., April 28, 2020 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB:EXDI) (the “Company”), a leading producer of hemp and hemp-derived specialty cannabinoid products, announced today that it...
NovelStem Announces New Research Collaborations for Stem-Cell Technology Platform in Cancer Immunotherapy and COVID-19 Resistance; Reports Progress Identifying Genetic Resistance to Additional Anti-Cancer Treatments
April 21, 2020 08:30 ET
|
NovelStem International Corp.
Screening of resistance diagnostics completed for twelve standard-of-care cancer treatments representing a significant portion of cancer treatment protocols. COVID-19 research collaboration initiated...
CENTOGENE Announces Changes in Supervisory Board
March 17, 2020 15:39 ET
|
Centogene AG
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, March 17, 2020 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world...
American Gene Technologies To Attend J.P. Morgan Healthcare Conference 2020
January 08, 2020 08:30 ET
|
American Gene Technologies
ROCKVILLE, Md., Jan. 08, 2020 (GLOBE NEWSWIRE) -- American Gene Technologies announced today that its Chief Executive Officer, Jeff Galvin, will attend the 38th annual J.P. Morgan Healthcare...
BioReference Laboratories Showcases 2019 Growth through the Addition of Cutting Edge Tests, Greater Access to Services, and Optimized Patient Experience
December 19, 2019 12:00 ET
|
Bio-Reference Laboratories
Elmwood Park, NJ, Dec. 19, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., an OPKO Health Company, along with its genetics and genomics laboratory, GeneDx, Inc., and oncology, urology and...
Definitive Research Study Shows Genes Contribute Only 5-10% to a Person’s Chance of Developing a Disease
December 18, 2019 08:00 ET
|
Molecular You Corporation
VANCOUVER, British Columbia, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Molecular You Corp announces the publication of a new research study led by one of its chief scientists, Dr. David Wishart, which...